Human Parathyroid Hormone 1–34 Prevents Bone Loss in Experimental Biliary Cirrhosis in Rats
Authors:
- Yankel GabetYGYankel Gabet
- Arza SteimatzkyASArza Steimatzky
- Gilad HamdaniGHGilad Hamdani
- Itai BabIBItai Bab
- Zvi AckermanZAZvi Ackerman
- Miron WeinrebMWMiron Weinreb
- 1 January 2008
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 134 (1) , 259-267
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Fracture Risk in People With Primary Biliary Cirrhosis: A Population-Based Cohort StudyGastroenterology, 2006
- Osteoporosis in Primary Biliary Cirrhosis: A Randomized Trial of the Efficacy and Feasibility of Estrogen/ProgestinDigestive Diseases and Sciences, 2006
- Alendronate Improves Bone Mineral Density in Primary Biliary Cirrhosis: A Randomized Placebo-Controlled Trial * #Hepatology, 2005
- Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosisJournal of Hepatology, 2005
- Bone mineral metabolism and histomorphometry in rats with cholestatic liver diseaseLiver International, 2002
- Bone disease in primary biliary cirrhosis: independent indicators and rate of progressionJournal of Hepatology, 2001
- Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trialJournal of Hepatology, 2000
- Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.Journal of Clinical Investigation, 1995
- Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosisBone, 1993
- Bone Loss and Reduced Osteoblast Function in Primary Biliary CirrhosisAnnals of Internal Medicine, 1985